Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1

Status

Completed 8Terminated 3Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 3

Conditions

Anemia 3

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × epoetin beta × Clear all
NCT00875004 2024-06-26

PLATON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Terminated
27 enrolled
Classical hematology

Anemia

NCT02608060 2016-11-02

A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B

Hoffmann-La Roche

Phase 4 Terminated
4 enrolled
Classical hematology

Anemia

NCT02624141 2016-11-02

A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy

Hoffmann-La Roche

Phase 4 Terminated
10 enrolled
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡